MPS Pharmaa Limited will halt trading for insiders following the release of Q3 2026 results
MPS Pharmaa Limited, formerly Advik Laboratories Limited, will close its trading window for directors, promoters, key managerial personnel, other designated persons/employees and their immediate relatives from October 1, 2026, until 48 hours after the unaudited financial results for the quarter ending September 30, 2026, are made public, in compliance with SEBI regulations.